Cover
Cover | Mar. 23, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Mar. 23, 2022 |
Entity Registrant Name | Recursion Pharmaceuticals, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-40323 |
Entity Tax Identification Number | 46-4099738 |
Entity Address, Address Line One | 41 S Rio Grande Street |
Entity Address, City or Town | Salt Lake City |
Entity Address, State or Province | UT |
Entity Address, Postal Zip Code | 84101 |
City Area Code | 385 |
Local Phone Number | 269 - 0203 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Class A Common Stock, par value $0.00001 per share |
Trading Symbol | RXRX |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity Central Index Key | 0001601830 |
Amendment Flag | false |
Document Fiscal Year Focus | 2021 |
Document Fiscal Period Focus | FY |